Atropine
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 6 |
Source: | FDA Structured Product Label |
---|
Side effects: | 7 |
Source: | medicines.org.au |
---|
Side effects: | 9 |
Source: | FDA Structured Product Label |
---|
Side effects: | 15 |
Source: | FDA Structured Product Label |
---|
Side effects: | 18 |
Source: | medicines.org.au |
---|
Side effects: | 21 |
Source: | FDA Structured Product Label |
---|
Side effects: | 22 |
Source: | FDA Structured Product Label |
---|
Side effects: | 22 |
Source: | FDA Structured Product Label |
---|
Side effects: | 25 |
Source: | FDA Structured Product Label |
---|
Side effects: | 26 |
Source: | FDA Structured Product Label |
---|
Side effects: | 27 |
Source: | Medsafe |
---|
Side effects: | 28 |
Source: | FDA Structured Product Label |
---|
Side effects: | 30 |
Source: | FDA Structured Product Label |
---|
Side effects: | 30 |
Source: | FDA Structured Product Label |
---|
Side effects: | 30 |
Source: | FDA Structured Product Label |
---|
Side effects: | 31 |
Source: | FDA Structured Product Label |
---|
Side effects: | 31 |
Source: | FDA Structured Product Label |
---|
Side effects: | 37 |
Source: | medicines.org.au |
---|
Side effects: | 38 |
Source: | FDA Structured Product Label |
---|
Side effects: | 126 |
Source: | FDA |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|